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Abstract Bovine serum albumin (BSA) hollow micro-
capsules were fabricated through glutaraldehyde (GA)
mediated covalent layer-by-layer assembly. The GA cross-
linking of the adsorbed BSA on the colloidal particles
enabled their surfaces to be covered by reactive aldehyde
groups, which reacted with BSA molecules to result in
another covalently linked layer. Repeating of this cycle
could then yield particles coated with BSA multilayers.
Hollow microcapsules well dispersed in water were
obtained after core removal. The good integrity and
morphology of the BSA capsules were confirmed and
characterized by confocal laser scanning microscopy,
scanning electron microscopy and scanning force micros-
copy. The obtained BSA microcapsules possess reversible
pH response, i.e., the capsules are permeable to macro-
molecules below pH 4 or above pH 10, while imper-
meable in between. The mechanisms of permeability
transition were discussed. Using this property, dextran,
with a molecular weight of ~155 kDa, was successfully
loaded.
Keywords Bovine serum albumin . Glutaraldehyde .
Covalent layer-by-layer . pH-responsive .Microcapsules
Introduction
Protein nano-/microspheres and capsules for controlled and/
or sustained release have attracted considerable attention for
pharmaceutical and other applications [1–9]. As natural
biomacromolecules, proteins are generally considered to be
biocompatible and biodegradable. Most previous studies
focused on different kinds of albumins [1–3], milk protein
caseins [4–7], as well as whey proteins [8, 9], because they
are abundant in nature and inexpensive. The most frequent-
ly employed procedure for fabricating the protein micro-
spheres is as follows. An aqueous solution of proteins
which may contain drugs is dispersed in an organic phase to
form a reverse emulsion. Then cross-linking of the droplets
is conducted to stabilize the structure, resulting in the
microspheres [3]. Although the droplet size of the emul-
sion, and thus the resulting microsphere size, is determined
by the nature of the dispersion, the spheres with smaller
size and narrower size distribution are difficult to obtain.
By other methods such as desolvation of the protein
solution followed by cross-linking [10] or electrospray
drying [11], protein nanoparticles can be fabricated.
Compared with spheres, hollow protein capsules have
larger capacity to load desired substances. Several
approaches have been developed to fabricate hollow protein
capsules. For example, bovine serum albumin (BSA)
capsules with disulfide cross-linked shells of ~50 nm and
cores containing air or non-aqueous liquid were prepared
using ultrasonic emulsification [12, 13]. In another case, the
hollow protein capsules with a size of tens of microns were
fabricated through protein adsorption on the pendent
organic droplets followed by evaporation of the organic
solvent [14]. However, the above-mentioned methods are
not applicable for fabricating capsules with defined size,
wall thickness and compositions. More recently, a new
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method combining colloidal templating and layer-by-layer
(LbL) assembly [15, 16], followed by core removal,
produces hollow microcapsules with precisely controlled
structures and properties [17–19]. Of special interest is that
it is possible to tune the stimuli-responsive properties of the
capsule by incorporation of functional molecules into their
wall or interior, thus the loading and subsequent release of
diverse substances into/from the microcapsules can be
controlled in a desired manner. By this method, the hollow
microcapsules with proteins or enzymes as one of the wall
compositions also have been obtained [20–23]. But in most
of the cases, the capsule walls are based on the electrostatic
interaction.
Glutaraldehyde (GA) is most widely used as a cross-
linking reagent for preparation of protein spheres and capsules
because its aldehyde groups can easily react with amine
groups at mild conditions. In our previous studies, GA was
used to cross-link polyelectrolyte microcapsules to manipulate
their properties [24, 25]. More recently, we developed a GA-
mediated covalent layer-by-layer assembly method to fabri-
cate single component polyelectrolyte microcapsules [26,
27]. Hemoglobin capsules and nanotubes with retained
activity were fabricated in a similar way [28, 29]. The single
component polyelectrolyte microcapsules are robust and
their properties can be controlled by the molecular weight
of used polyelectrolyte [26, 27]. However, due to the high
cross-linking density the capsules lost their stimuli-response.
BSA has a high content of charged residues of amino
acids, such as aspartic and glutamic acids, lysine, and
arginine [30, 31]. GA only cross-links the amine group of
lysine [32], while the other charged residues of amino acids
still exist. Consequently, pH response of the resultant
products can be expected. Moreover, previous studies have
shown that the GA-cross-linked albumin microspheres are
relatively non-immunogenic and biodegradable in muscle
without adverse tissue reactions [2]. Therefore, the GA
cross-linked BSA spheres/capsules are promising for
pharmaceutical applications. Herein, we describe the
preparation of BSA microcapsules fabricated in a covalent
layer-by-layer assembly manner through GA cross-linking.
In this approach, BSA is first assembled on the surfaces of
the colloidal templates. Then the coated particles are
suspended in GA solution to cross-link the adsorbed BSA
layer and activate the surface for the next covalent
assembly of BSA. This procedure is repeated several times
until the desired layer number is reached. Hollow capsules
are obtained by removal of the cores. The microstructure of
the obtained BSA microcapsules is investigated by confocal
laser scanning microscopy (CLSM), scanning electron
microscopy (SEM) and scanning force microscopy (SFM).
The capsules show reversible pH-controlled permeability,
which can be used to encapsulate macromolecules. The
possible mechanisms of pH response are discussed.
Experimental section
Materials
BSA, tetramethylrhodamine isothiocyanate labeled dex-
tran (TRITC-dextran, Mw~155 kDa), rhodamine 6G
(Rd6G), manganese sulfate hydrate (MnSO4·H2O), diso-
dium ethylenediaminetetraacetate dihydrate (EDTA),
ammoniumhydrogencarbonate (NH4HCO3) and glutaralde-
hyde (GA, 50 wt.% solution in water) were all obtained
from Sigma-Aldrich. All the chemicals were used as
received. The water used in all the experiments was
prepared in a three-stage Millipore Milli-Q Plus 185
purification system and had a resistivity higher than
18.2 MΩ. Spherical MnCO3 microparticles with an average
diameter of 7.4±0.4 μm were synthesized according to
literature by mixing MnSO4 and NH4HCO3 solutions
[33, 34].
Methods
Multilayer build-up onto planar substrate
Silicon wafers were treated with H2O2/H2SO4 (30/70 v/v)
solution for 1 h and thoroughly rinsed with water. The
pre-treated substrates were sequentially immersed into
BSA (4 mg/ml, in 0.5 M NaCl, pH=4.7) and GA
solutions (2%) for 30 min, with three water rinses at each
interval. After each BSA assembly, the surface water of
the multilayer was blown away by flowing nitrogen and
the thickness of the film was measured immediately by
ellipsometry.
Fabrication of hollow protein microcapsules
BSA was adsorbed onto the MnCO3 microparticles under
the same conditions employed for its multilayer construc-
tion on planar substrate. After BSA adsorption, the excess
proteins were removed by centrifugation at 300 ×g for
5 min, and the coated particles were washed three times
with water. Then the particles were dispersed in the GA
solution for 30 min, followed by three washings. The cross-
linked and surface activated particles were dispersed in the
protein solution again. This procedure was repeated until
ten BSA layers were assembled. The coated particles were
further cross-linked with 2% GA solution for 12 h to
stabilize the structure. After washing with water five times,
the coated particles were incubated in 0.1 M HCl solution
for 30 min under continuous shaking to remove the cores.
The resultant capsules were washed three times with
0.01 M EDTA solution to rinse off the Mn2+. Finally, the
capsules were washed three times with water and dispersed
in water.
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Ellipsometry
Ellipsometry was performed using an optical null ellips-
ometer (Multiskop Ellipsometer, Optrel GmbH) with a He–
Ne laser at 632.8 nm at an angle of 70°. Silicon wafers were
used as the substrates for the multilayer formation and were
cleaned as described above. A refractive index value of
1.32 for BSA multilayer was measured from ten-layer film
and used for all the calculations. Each point was averaged
from ten individual measurements.
Confocal laser scanning microscopy (CLSM)
Confocal images were taken with a Leica confocal scanning
system mounted to a Leica Aristoplan and equipped with a
100× oil immersion objective with a numerical aperture
(NA) of 1.4. For visualization, Rd6G was used to stain the
BSA capsules. To investigate the permeability, a drop of the
capsule suspension was mixed with the fluorescent probes
solution with same pH and observed after 30 min.
Scanning electron microscopy (SEM)
Samples were prepared by applying a drop of the capsule
suspension onto glass slides. After dried overnight, the
samples were sputtered with gold and measured by a
Gemini Leo 1550 instrument at an operation voltage of
3 keV.
Scanning force microscopy (SFM)
A drop of the sample suspension was applied onto freshly
cleaved mica and dried overnight at room temperature.
Images were obtained by a Digital Instruments nanoscope
IIIa Multimode SFM (Digital Instruments Inc., Santa
Barbara, CA) in air at room temperature using the tapping
mode.
ζ-potential measurement
The ζ-potentials of BSA microcapsules were measured at
different pHs by a Zetasizer Nanoinstrument Nano Z
equipment. The pH was adjusted by 0.1 M NaOH or HCl.
Each value was averaged from three parallel measurements.
Results and discussion
Protein multilayer built up on planar substrate
The reaction of GA with diverse proteins has been
extensively studied and the reaction is pH-dependent [35].
Jansen et al. [36] showed that the optimum pH for GA
insolubilization varies from proteins to proteins. Specially,
the pH for the most rapid insolubilization of BSA was
found to be nearly the same as its isoelectricpoint (pI; pH
4.7). The existence of an optimum pH suggests the
important role of the protein charge on the intermolecular
cross-linking which is required for the formation of
insoluble protein layer. The charge on the protein may
regulate cross-linking, which is maximal when the repul-
sive charges are minimal. One more recent study also
confirmed that shielding the electrostatic repulsion is
necessary for the successful LbL assembly of like charged
polyelectrolyte [37]. So here the pH 4.7 (the pI of BSA)
and relatively high ionic strength (0.5 M NaCl) were used
for the construction of BSA multilayers. First, the BSA
multilayers were assembled on silicon wafer for the sake of
monitoring the film growth by ellipsometry. Figure 1 shows
that the film thickness increases steadily in a linear way
with the increase of layer number. The average increment of
one BSA layer is about 3 nm. The crystal structure of
albumin reveals a heart-shape molecule that can be
approximated to an equilateral triangle with sides of
~8 nm and a depth of ~3 nm [31]. Therefore, here each
absorbed BSA layer is more likely a monolayer. These
results confirm that mediated via GA, the BSA multilayers
can be successfully built up on a planar surface and its
thickness increment can be controlled at the nanometer
scale.
Hollow protein microcapsules
In order to obtain capsules with good integrity, the free-
standing multilayers of the microcapsules should be strong
enough to resist the osmotic pressure during the core
removal process [38, 39]. Therefore, the ten-layer BSA


















Fig. 1 The thickness of the BSA multilayers formed on the silicon
wafer as a function of layer number, determined by ellipsometry. The
solid line is a linear fit of the data
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coated particles were further cross-linked with GA for 24 h
to stabilize the structure. The post treatment with longer
reaction time is necessary because the reaction of GA with
lysine residues is progressive with time, probably depend-
ing on the accessibility of the amino groups [40, 41]. Then
the MnCO3 templates were removed and the BSA capsules
were washed with EDTA solution and water. Visualized
under CLSM (Fig. 2a), the obtained microcapsules are well
dispersed in water and resemble the shape of their templates
as those fabricated by the traditional electrostatic assembly.
However, their size shrinks from 7.4±0.4 μm (core size) to
5.1±0.3 μm. Size shrinkage after core removal was also
observed for polypeptide microcapsules and nanoporous
protein spheres [42, 43]. Molecular relaxation should
contribute partially to this phenomenon. Recent studies
show that the balance between hydrophobicity and hydro-
philicity contributes to surface energy of the capsules, which
may cause shrinkage if hydrophobicity dominates, or expan-
sion if the lateral electrostatic repulsion dominates [44].
After evaporation of the water, the hollow capsules
collapse (Fig. 2b) to a pancake topology without typical
folds and creases often observed in traditional multilayer
microcapsules [18]. The SFM images provide more clear
visualization (Fig. 3a). Here we make two assumptions for
estimating the wall thickness after shrinkage: the thickness





Fig. 2 CLSM image (a) and
SEM image (b) of the ten-layer
BSA hollow microcapsules. The
inset of b is a magnified cap-
sule; the scale bar=2 μm
Fig. 3 SFM image (a) of the ten-layer BSA hollow microcapsules. b is a higher magnification of a flat part of the capsule shown in (a)
1106 Colloid Polym Sci (2008) 286:1103–1109
before core removal is equal to that on the planar silicon
wafer, and there is no material loss during the capsule
shrinkage after core removal, thus the volume of the wall
should keep constant in a dry state. Therefore, the thickness
of the capsule walls should increase after capsule shrinkage,
and the double wall thickness is estimated as ~126 nm. This
value is far larger than that of the traditional polyelectrolyte
multilayers with the same layer number (~40 nm) [18].
However, it is still smaller than the apparent double wall
thickness (~300 nm) measured from the minimum height of
the capsules in the SFM images, indicating that more
materials are adsorbed onto the rough MnCO3 particles and
the capsules may not be completely collapsed and flattened.
These facts can explain the morphology difference between
the BSA microcapsules and the polyelectrolyte micro-
capsules observed from the SEM and AFM images. The
capsule surface shows a rough morphology with a ridge-
like structure (root-mean-squared roughness (RMS) on
1 μm×1 μm was 11.3 nm; Fig. 3b). Grains and domains
ranging from tens to hundreds of nanometers also can be
seen. We suppose that the shrinkage of the capsule should
greatly influence the surface morphology to induce the
wrinkled and rough structure.
pH-controlled permeability of the protein microcapsules
The permeability of the hollow BSA capsules is particularly
interesting due to its close relationship with diverse
applications. Thus the permeation of low-molecular-weight
dyes as well as macromolecules was investigated by CLSM
after incubation for 30 min. It was found that the BSA
microcapsules are permeable for low-molecular-weight
dyes, such as Rd6G (data not shown). However, the
situation is different for TRITC-dextran with a molecular
weight of 155 kDa. Representative CLSM images obtained
at different pHs are shown in Fig. 4. At acidic and alkaline
conditions, e.g., pH 3.5 and 10.3, respectively (Fig. 4a,c),
the capsules have the same fluorescence intensity inside as
the bulk solution, implying that the dextran can penetrate
inside. By sharp contrast, at neutral pH (pH 6.5), the
ca bpH 3.5 pH 6.5 pH 10.3
Fig. 4 CLSM images of the ten-layer BSA microcapsules after mixed
with TRITC-dextran (Mw~155 kDa) for 30 min at different pHs: a pH
3.5, b pH 6.5 and c pH 10.3. The capsules are impermeable to
macromolecules in the pH range of 4~10, while are permeable below
pH 4 or above 10. Scale bar=10 μm
ba
Fig. 5 CLSM images of the
BSA microcapsules loaded with
TRITC-dextran (Mw~155 kDa)
through the pH-controlled per-
meability switching protocol.
The capsules were incubated
with TRITC-dextran solution at
(a) pH 3.5, (b) pH 10.3 for
30 min and washed after the pH
was adjusted to 6.5. Scale bar=
10 μm
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interiors of the capsules remain dark at least for 30 min
(Fig. 4b), implying that the dextran can not penetrate inside.
This image reveals also that most of the capsules preserve
their good integrity after core removal. We checked the pH
range of 1~12. The transition points of permeability for
macromolecules were found around pH 4 and pH 10. In
other words, the pH values for the TRITC-dextran to
permeate inside are <4 and >10. It is worth mentioning that
the size of the capsule remained constant (5.1±0.3 μm) at
pH below 10, while increased to 6.1±0.3 μm at pH above
10. Both of the pH-responsive permeability and swelling
are reversible.
The pH-responsive properties have been reported for
different multilayer capsules [25, 45–50]. It has been
suggested that the change of the polyelectrolyte charges
upon pH variation might induce reorganization of the wall
structure or loosen the polyelectrolyte networks, enabling
the macromolecules to penetrate [25, 45, 50]. The lateral
electrostatic repulsion between the same net charges
resulting from the pH change is considered as the main
driving force to induce a swelling of the whole structure
[46–48]. Moreover, the attraction of counterions by the net
charge may increase the local osmotic pressure and
contribute to the swelling effect [48]. Generally, the
swelling of the capsules is accompanied by the increase of
permeability [46, 51]. This mechanism should be applicable
to the swelling and the enhanced permeability of the BSA
capsules at pHs above 10. Albumins are characterized by a
high content of charged amino acids, such as aspartic and
glutamic acids, lysine, and arginine [30, 31]. GA cross-
linking only modifies the amine group of lysine [32], so the
carboxyls still exist and are almost fully charged at pH
above 10 to gain a net negative charge in the capsule walls.
To confirm this point, the ζ-potentials of the BSA hollow
capsules were investigated at different pHs. The results
showed that at pH 10, the capsules are more negatively
charged (−23.8±3.5 mV) than that at pH 6.5 (−13.3±
1.9 mV). The result implies also although the capsules
possess net negative charge at neutral pH, the value is not
high enough to cause the swelling of the capsules.
Albumin was reported to undergo a major reversible
conformation change with changes of pH [30, 31]. In a
previous study [23], a permeability increase of human
serum albumin (HSA)/lipids microcapsules was also ob-
served at pH below 4.8. The expanded conformation of
HSA is believed to disorder the structure of lipid bilayers,
thus enhancing the permeation of macromolecules. To
investigate whether the conformation change near pH 4
induces the permeability change or not, we deposited the
BSA multilayers on the inner surface of a quartz cell and
filled the cell with water with pHs of 3.5, 4, and 4.5 then
measured the circular dichroism (CD) spectra. No obvious
difference was found between these spectra (data not
shown). We measured the ζ-potential of the BSA micro-
capsules at pH 4 also, and found a value of −1.4±1.2 mV.
Therefore, at least from the viewpoint of charge interaction,
we believe that the microstructure of the microcapsules
should have been similarly altered as that in the basic
solution, since the absolute variable values at lower and
higher pH are almost same (~10 mV).
The ability of reversible permeability switching provides
a facile and effective way to control the loading and release
of various macromolecules. For example, the capsules were
incubated in TRITC-dextran (Mw~155 kDa) solution at pH
3.5 or 10.5 for 30 min, and then the pH value was adjusted
to 6.5. After removal of the bulk solution by centrifugation
and washing, TRITC-dextran was successfully loaded into
the microcapsules as verified by the strong fluorescence
from the capsule interiors (Fig. 5). The encapsulated
macromolecules did not leak out at least for 2 weeks (data
not shown).
Conclusion
We describe here the fabrication of hollow BSA micro-
capsules through a GA-mediated covalent LbL assembly
method and subsequent core removal. The linear growth of
the BSA multilayers as a function of layer number was
monitored by ellipsometry, illustrating that the increment of
the thicknesses can be controlled in a nanometer scale.
These BSA capsules exhibit reversible pH-responsive
permeability. They are permeable for macromolecules at
pH below 4 or above 10, while are impermeable in between.
The permeability transition at pH 10 is attributed to the
swelling of the capsules as a result of charge repulsion.
Using this feature, macromolecules can be loaded and
sealed for at least for 2 weeks. This method can be extended
to other proteins and enzymes also, which are not only
biocompatible but also bioactive. The protein microcapsules
with pH-tunable permeability are relevant to many applica-
tions, especially those related with drug release.
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